These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2227107)

  • 21. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
    Parving HH; Hommel E; Damkjaer Nielsen M; Giese J
    BMJ; 1989 Aug; 299(6698):533-6. PubMed ID: 2507061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
    Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A
    Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Captopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy.
    Elving LD; Wetzels JF; de Nobel E; Hoitsma AJ; Berden JH
    Am J Kidney Dis; 1992 Dec; 20(6):559-63. PubMed ID: 1462982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients.
    Hansen KW; Klein F; Christensen PD; Sørensen K; Andersen PH; Møller J; Pedersen EB; Christiansen JS; Mogensen CE
    Diabete Metab; 1994; 20(5):485-93. PubMed ID: 7859897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
    Marre M; Chatellier G; Leblanc H; Guyene TT; Menard J; Passa P
    BMJ; 1988 Oct; 297(6656):1092-5. PubMed ID: 2848604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Ravid M; Brosh D; Levi Z; Bar-Dayan Y; Ravid D; Rachmani R
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):982-8. PubMed ID: 9625684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; Raffaele J; Tsalamandris C
    Am J Kidney Dis; 2001 May; 37(5):890-9. PubMed ID: 11325669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of nifedipine and captopril on liver blood flow in healthy subjects.
    Burggraaf J; Schoemaker RC; Kroon JM; Cohen AF
    Br J Clin Pharmacol; 1998 May; 45(5):447-51. PubMed ID: 9643616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible effect of angiotensin-converting enzyme inhibition on glomerular charge selectivity.
    Hansen PM; Mathiesen ER; Kofoed-Enevoldsen A; Deckert T
    J Diabetes Complications; 1995; 9(3):158-62. PubMed ID: 7548979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
    Diabetologia; 1996 May; 39(5):587-93. PubMed ID: 8739919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
    Elving LD; Wetzels JF; van Lier HJ; de Nobel E; Berden JH
    Diabetologia; 1994 Jun; 37(6):604-9. PubMed ID: 7926346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.
    Gambaro G; Kinalska I; Oksa A; Pont'uch P; Hertlová M; Olsovsky J; Manitius J; Fedele D; Czekalski S; Perusicová J; Skrha J; Taton J; Grzeszczak W; Crepaldi G
    J Am Soc Nephrol; 2002 Jun; 13(6):1615-25. PubMed ID: 12039991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
    Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indomethacin but not metoprolol reduces exercise-induced albumin excretion rate in type 1 diabetic patients with microalbuminuria.
    Rudberg S; Sätterström G; Dahlqvist R; Dahlquist G
    Diabet Med; 1993 Jun; 10(5):460-4. PubMed ID: 8334827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
    Parving HH; Hommel E; Smidt UM
    BMJ; 1988 Oct; 297(6656):1086-91. PubMed ID: 3143437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK; Chaturvedi N; Fuller J
    Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
    Viberti G; Mogensen CE; Groop LC; Pauls JF
    JAMA; 1994 Jan; 271(4):275-9. PubMed ID: 8295285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.